## åŒ»ç–— AI ç ”æŠ¥ä½¿ç”¨ç¤ºä¾‹ (Example)

### ç”¨æˆ·åœºæ™¯ Aï¼šæ‰‹åŠ¨æ‰§è¡Œ (å…³é”®è¯è§¦å‘)
**ç”¨æˆ·è¯·æ±‚**ï¼š`MDTç®€æŠ¥` æˆ– `è¯·ç»™æˆ‘ä¸€ä»½å…³äº AI åœ¨ MDT åä½œä¸­æœ€è¿‘ 48 å°æ—¶çš„æ·±åº¦ç ”æŠ¥`

### AI è¾“å‡ºå†…å®¹ (é»˜è®¤ Academic æ¨¡å¼)

```markdown
# ğŸ¥ æ·±åº¦åŒ»å­¦ç»¼è¿°: AI é©±åŠ¨çš„å¤šå­¦ç§‘ä¼šè¯Š (MDT)
**æ—¥æœŸ**: 2026-02-25 | **è¦†ç›–**: è¿‘ 48 å°æ—¶ | **æ ¸å¿ƒæ¨¡å¼**: Academic Default

## æ‘˜è¦ (Abstract)
è¿‡å» 48 å°æ—¶å†…ï¼Œé¡¶çº§åŒ»å­¦æœŸåˆŠä¸é¢„å°æœ¬å¹³å°å‘å¸ƒäº†å¤šé¡¹å…³äº AI å¢å¼º MDT å†³ç­–é€æ˜åº¦ä¸ä¸€è‡´æ€§çš„ç ”ç©¶ã€‚æ ¸å¿ƒè¶‹åŠ¿æ˜¾ç¤ºï¼Œç ”ç©¶ç„¦ç‚¹æ­£åœ¨ä»â€œå•ç‚¹ç®—æ³•ç²¾åº¦â€è½¬å‘â€œå¤šæ™ºèƒ½ä½“åä½œæµâ€ä¸â€œä¸´åºŠè·¯å¾„åˆè§„æ€§â€ã€‚

## æ£€ç´¢ç­–ç•¥ (Search Methodology)
- **å…³é”®è¯**: `("AI-driven MDT" OR "multidisciplinary team decision support") AND when:48h`
- **æ¥æº**: PubMed, Nature Medicine, MedRxiv (27 ä¸ªä¸“å®¶æºæ± )
- **æ—¶é—´çª—**: 2026-02-23 è‡³ 2026-02-25

## æŠ€æœ¯æ·±åº¦è°ƒç ” (In-depth Findings)

### 1. å¤šæ™ºèƒ½ä½“åä½œå†³ç­–æµçš„æ¼”è¿› (Agents in Clinic)
- **æŠ€æœ¯è„‰ç»œ**: è¯¥ç ”ç©¶æ˜¯åœ¨ *Nature Medicine (2025)* çš„ Agent-based æ¶æ„åŸºç¡€ä¸Šï¼Œè¿›ä¸€æ­¥é›†æˆäº† **â€œä¸´åºŠæŒ‡å—å¼ºå¯¹é½â€** æ¨¡å—ï¼Œè§£å†³äº†æ­¤å‰æ¨¡å‹æ˜“äº§ç”Ÿçš„â€œå»ºè®®æ¼‚ç§»â€é—®é¢˜ã€‚
- **æ ¸å¿ƒè´¡çŒ®**: æå‡ºäº†ä¸€ç§åä¸º `Synapse-MDT` çš„æ–°æ¶æ„ï¼Œåœ¨è‚¿ç˜¤å¤šå­¦ç§‘è¯„ä¼°ä¸­ï¼Œä¸äººç±»ä¸“å®¶å§”å‘˜ä¼šçš„ä¸€è‡´æ€§ä» 82% æå‡è‡³ 91%ã€‚
- **ä¼˜ç¼ºç‚¹**: 
  - `Pros`: æ˜¾è‘—é™ä½äº†ä¸“å®¶ä¼šè®®çš„é¢„å®¡è€—æ—¶ï¼›
  - `Cons`: å¯¹äºç½•è§ç—…ç—…ä¾‹ï¼Œæ¨¡å‹ç½®ä¿¡åº¦ä»å¤„äºè¾ƒä½æ°´å¹³ã€‚

### 2. ç”Ÿç‰©å­¦ä¿çœŸåº¦ä¸è™šæ‹Ÿå¯¹ç…§ç»„çš„åº”ç”¨
- ... (æ­¤å¤„çœç•¥éƒ¨åˆ†å­¦æœ¯ç»†èŠ‚) ...

## ä¸´åºŠè¯æ®è´¨é‡è¯„ä»· (Evidence Quality)
- **æ ·æœ¬é‡**: 1200+ ä¸´åºŠå›é¡¾æ€§æ¡ˆä¾‹ã€‚
- **åå€šè¯„ä¼°**: å­˜åœ¨è½»å¾®çš„åœ°åŸŸæ ·æœ¬åå·®ï¼ˆä¸»è¦æºè‡ªåŒ—ç¾æ•°æ®é›†ï¼‰ï¼Œå¯¹äºšæ´²æ‚£è€…çš„æ™®é€‚æ€§éœ€è¿›ä¸€æ­¥éªŒè¯ã€‚
- **ç›‘ç®¡å¯¹æ ‡**: ç¬¦åˆ FDA æ•°å­—å¥åº·å“è¶Šä¸­å¿ƒå…³äºâ€œé€æ˜ AIâ€çš„æœ€ä¸¥è‹›æŠ«éœ²è¦æ±‚ã€‚

## è®¨è®ºä¸ç»“è®º
- **ç»“è®º**: AI ä¸å†æ˜¯ MDT çš„è¾…åŠ©å·¥å…·ï¼Œè€Œæ­£åœ¨è¿›åŒ–ä¸º**â€œå†³ç­–å®ˆé—¨äººâ€**ï¼Œè´Ÿè´£åˆç­›è¯æ®ä¸æ ‡è®°å†²çªç‚¹ã€‚
- **ä¸‹ä¸€æ­¥å»ºè®®**: å»ºè®®å…³æ³¨ä¸‹å‘¨å³å°†åœ¨æ¬§æ´²è‚¿ç˜¤å†…ç§‘å­¦ä¼š (ESMO) å‘å¸ƒçš„ real-world æ•°æ®æ›´æ–°ã€‚

## å‚è€ƒæ–‡çŒ® (References)
1. *Synapse-MDT: Collaborative Intelligence in Oncology.* [URL]
2. *Transparency in AI-driven Clinical Pathways.* [URL]
```

---

### ç”¨æˆ·åœºæ™¯ Bï¼šå®šæ—¶ä»»åŠ¡ (Cron/Feishu Push)
**ä»»åŠ¡æŒ‡ä»¤**ï¼š`è¯·ä½¿ç”¨ medical-ai-research æŠ€èƒ½ï¼Œé’ˆå¯¹ åŒ»ç–—å¤§æ¨¡å‹ æ‰§è¡Œæ¯æ—¥æ’­æŠ¥å¹¶å°†ç»“æœå‘é€åˆ°å½“å‰é¢‘é“ã€‚`

### æ¨é€æ•ˆæœ (ç®€åŒ–ç‰ˆ)
> ğŸ¥ **åŒ»ç–—å¤§æ¨¡å‹ æ¯æ—¥æ·±åº¦æ’­æŠ¥**
> 1. **æ ¸å¿ƒè®ºæ–‡**: [è®ºæ–‡ A] è§£å†³äº†é•¿åºåˆ—åŒ»å­¦å½±åƒç†è§£çš„å¹»è§‰é—®é¢˜ã€‚
> 2. **æ·±åº¦æ€è€ƒ**: è¯¥æ¨¡å‹é€šè¿‡å¤šæ¨¡æ€å¯¹é½æœ‰æ•ˆè¯†åˆ«äº†æ­¤å‰å¿½è§†çš„å¾®å°ç—…ç¶ã€‚
> 3. **è¡ŒåŠ¨å»ºè®®**: å»ºè®®å†…éƒ¨å›¢é˜Ÿåœ¨ EMR è‡ªåŠ¨åŒ–æ¨¡å—ä¸­å¤ç”¨è¯¥æ³¨æ„åŠ›æœºåˆ¶ã€‚
> ---
> *è¯¦ç»†å…¨æ–‡è¯·ç‚¹å‡» [æŸ¥çœ‹æŠ¥å‘ŠåŸæ–‡]*

---

### ç”¨æˆ·åœºæ™¯ Cï¼šæ ¸å¿ƒè°ƒç ” (OCR å™ªå£°æ–¹å‘)
**ç”¨æˆ·è¯·æ±‚**ï¼š`ocrç®€æŠ¥`

### AI è¾“å‡ºå†…å®¹ (åŸºäº 2026 å¹´ 2 æœˆå®æ—¶æ•°æ®æ¨¡æ‹Ÿ)

```markdown
# ğŸ¥ æ·±åº¦åŒ»å­¦ç»¼è¿°: OCR å™ªå£°å¯¹ä¸´åºŠ NLP ä»»åŠ¡çš„å½±å“
**æ—¥æœŸ**: 2026-02-25 | **è¦†ç›–**: è¿‘ 48 å°æ—¶ | **æ¨¡å¼**: Academic (é»˜è®¤)

## æ‘˜è¦ (Abstract)
æœ¬æ’­æŠ¥èšç„¦äºè¿‘æœŸå…³äºåŒ»ç–—æ–‡ä¹¦æ•°å­—åŒ–è´¨é‡çš„æ ¸å¿ƒçªç ´ã€‚è™½ç„¶ 48 å°æ—¶å†…é¡¶çº§æœŸåˆŠå¤„äºå®¡ç¨¿å‘¨æœŸï¼Œä½†æˆ‘ä»¬æ•è·äº† 2026 å¹´åˆå‘å¸ƒçš„ **"Noise-Aware Training (NAT)"** å…³é”®æŠ€æœ¯æ–¹æ¡ˆåŠ 2025 å¹´é’ˆå¯¹åŒ»ç–— OCR å™ªå£°çš„æ··åˆè¯†åˆ«åŸºå‡†ã€‚

## æ£€ç´¢ç­–ç•¥ (Search Methodology)
- **å…³é”®è¯**: `("OCR induced noise" OR "OCR error") AND ("NER" OR "Information Extraction") when:48h`
- **æ¥æº**: PubMed, ACL Anthology, arXiv, Journal of IJSRA (27 ä¸ªä¸“å®¶æºæ± )
- **æ—¶é—´çª—**: 2026-02-23 è‡³ 2026-02-25

## ğŸ“‘ è®ºæ–‡å…¨æ–‡åˆ—è¡¨ (Exact Sourcing - å…¨é‡è¦†ç›–)
1. **[Hybrid Approaches for NER in Noisy OCR Medical Records](https://journalijsra.com/content/2025/01/21/hybrid-ner-medical)** (2025)
2. **[Noise-Aware Named Entity Recognition for Historical/Clinical Documents](https://arxiv.org/abs/2601.07119)** (2026-01-28)
3. **[The Impact of OCR Quality on NLP Tasks: A Systematic Study](https://universiteitleiden.nl/research/ocr-quality-nlp)** (2025 Research)

---

## æŠ€æœ¯æ·±åº¦è°ƒç ” (In-depth Findings)

### 1. [Hybrid Approaches for NER in Noisy OCR Medical Records](https://journalijsra.com/content/2025/01/21/hybrid-ner-medical)
- **æŠ€æœ¯è„‰ç»œ**: è¯¥ç ”ç©¶ç”± *IJSRA (2025)* å‘å¸ƒï¼Œä¸“é—¨é’ˆå¯¹åŒ»ç–—è®°å½•æ•°å­—åŒ–ä¸­çš„å­—ç¬¦æ‰­æ›²ã€‚
- **ä¸´åºŠè´¡çŒ®**: è¯æ˜äº†å°†â€œç¡®å®šæ€§è§„åˆ™â€ä¸â€œTransformer åµŒå…¥â€ç»“åˆåï¼Œå¯¹åŒ»ç–—ç¼©ç•¥è¯­çš„è¯†åˆ«å¬å›ç‡æå‡äº† 18%ã€‚
- **ä¼˜åŠ£åˆ†æ**:
  - `Pros`: å¯¹é¢†åŸŸç‰¹å®šæœ¯è¯­ï¼ˆDomain-specific acronymsï¼‰æåº¦é²æ£’ã€‚
  - `Cons`: æ¨¡å‹ä½“ç§¯è¾ƒå¤§ï¼Œè¾¹ç¼˜ç«¯éƒ¨ç½²å›°éš¾ã€‚

### 2. [Noise-Aware Named Entity Recognition](https://arxiv.org/abs/2601.07119)
- **æ ¸å¿ƒå‘ç°**: æå‡ºäº†ä¸€ç§ **NAT (Noise-Aware Training)** æ¶æ„ï¼Œé€šè¿‡åœ¨è®­ç»ƒé›†ä¸­é¢„å…ˆæ³¨å…¥æ¨¡æ‹Ÿ OCR å™ªå£°ï¼Œä½¿æ¨¡å‹å¯¹â€œå­—ç¬¦çº§æŠ–åŠ¨â€å…·æœ‰åŸç”ŸæŠ—æ€§ã€‚
- **æ¼”è¿›å…³ç³»**: è¯¥ç ”ç©¶æ˜¯ 2026 å¹´åˆ NER é²æ£’æ€§é¢†åŸŸçš„ä»£è¡¨ä½œï¼Œè™½é¦–å‘äºæ•™è‚²æ–‡ä¹¦ï¼Œä½†åœ¨ä¸´åºŠ NLP è¿ç§»æµ‹è¯•ä¸­è¡¨ç°å“è¶Šã€‚

### 3. [The Impact of OCR Quality on NLP Tasks](https://universiteitleiden.nl/research/ocr-quality-nlp)
- **å…³é”®é˜ˆå€¼**: å®éªŒç¡®è®¤ 70%-80% çš„ OCR ç²¾åº¦æ˜¯åç»­å†³ç­–ç³»ç»Ÿçš„â€œç”Ÿå‘½çº¿â€ã€‚

## è®¨è®ºä¸ç»“è®º
- **ç»“è®º**: è§£å†³ OCR å™ªå£°çš„é»„é‡‘ç»„åˆå·²ç¡®å®šä¸ºï¼š**å‰ç«¯ NAT è®­ç»ƒ + åç«¯æ··åˆè¯­ä¹‰æ ¡éªŒ**ã€‚
- **å»ºè®®è¡ŒåŠ¨**: å»ºè®®åœ¨å¤„ç† EMR æ•°æ®æ—¶ï¼Œå¼•å…¥ NAT å¢å¼ºå‹çš„é¢„è®­ç»ƒæƒé‡ã€‚

## å‚è€ƒæ–‡çŒ® (References)
- 1. *Hybrid Approaches for NER* - https://journalijsra.com/content/2025/01/21/hybrid-ner-medical
- 2. *Noise-Aware NER* - https://arxiv.org/abs/2601.07119
- 3. *Impact of OCR Quality* - https://universiteitleiden.nl/research/ocr-quality-nlp
```
